Scientists train Patients' own cells to fight advanced gut cancers
NCT ID NCT04960072
Summary
This early-stage study is testing a personalized treatment called TIL therapy for people with advanced gastrointestinal cancers that have come back or stopped responding to standard treatments. Doctors take a sample of a patient's tumor, grow special immune cells from it in a lab, and then infuse a large number of these cells back into the patient to try to attack the cancer. The main goals are to see if this approach is safe and if it can shrink tumors and help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Tenth People's Hospital
RECRUITINGShanghai, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.